Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model

Astrid Sydow, Ann Van Der Jeugd, Fang Zheng, Tariq Ahmed, Detlef Balschun, Olga Petrova, Dagmar Drexler, Lepu Zhou, Gabriele Rune, Eckhard Mandelkow, Rudi D'Hooge, Christian Alzheimer, Eva Maria Mandelkow

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The accumulation of proteins such as Tau is a hallmark of several neurodegenerative diseases, e.g., frontotemporal dementia (FTD). So far, many mouse models of tauopathies have been generated by the use of mutated or truncated human Tau isoforms in order to enhance the amyloidogenic character of Tau and to mimic pathological processes similar to those in FTD patients. Our inducible mice express the repeat domain of human Tau (Tau RD) carrying the FTDP-17 mutation ΔK280 in a "pro-aggregant" and an "anti-aggregant" version. Based on the enhanced tendency of Tau to aggregate, only the "pro-aggregant" Tau RD mice develop Tau pathology (hyperphosphorylation, coassembly of human and mouse Tau, synaptic loss, and neuronal degeneration). We have now carried out behavioral and electrophysiological analyses showing that only the pro-aggregant Tau RD mice have impaired learning/memory and a distinct loss of LTP. Remarkably, after suppressing the pro-aggregant human Tau RD, memory and LTP recover, while neuronal loss persists. Aggregates persist as well but change their composition from mixed human/mouse to mouse Tau only. The rescue of cognition and synaptic plasticity is explained by a partial recovery of spine synapses in the hippocampus. These results indicate a tight relationship between the amyloidogenic character of Tau and brain malfunction, and suggest that the cognitive impairment is caused by toxic human Tau RD species rather than by mouse Tau aggregates.

Original languageEnglish
Pages (from-to)432-437
Number of pages6
JournalJournal of Molecular Neuroscience
Volume45
Issue number3
DOIs
Publication statusPublished - Nov 2011
Externally publishedYes

Fingerprint

Frontotemporal Dementia
Tauopathies
Neuronal Plasticity
Poisons
Pathologic Processes
Neurodegenerative Diseases
Synapses
Cognition
Hippocampus
Protein Isoforms
Spine
Learning
Pathology
Mutation
Brain

Keywords

  • Aggregation
  • Frontotemporal dementia
  • Tau
  • Tauopathy
  • Transgenic mouse models

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Sydow, A., Van Der Jeugd, A., Zheng, F., Ahmed, T., Balschun, D., Petrova, O., ... Mandelkow, E. M. (2011). Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model. Journal of Molecular Neuroscience, 45(3), 432-437. https://doi.org/10.1007/s12031-011-9604-5

Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model. / Sydow, Astrid; Van Der Jeugd, Ann; Zheng, Fang; Ahmed, Tariq; Balschun, Detlef; Petrova, Olga; Drexler, Dagmar; Zhou, Lepu; Rune, Gabriele; Mandelkow, Eckhard; D'Hooge, Rudi; Alzheimer, Christian; Mandelkow, Eva Maria.

In: Journal of Molecular Neuroscience, Vol. 45, No. 3, 11.2011, p. 432-437.

Research output: Contribution to journalArticle

Sydow, A, Van Der Jeugd, A, Zheng, F, Ahmed, T, Balschun, D, Petrova, O, Drexler, D, Zhou, L, Rune, G, Mandelkow, E, D'Hooge, R, Alzheimer, C & Mandelkow, EM 2011, 'Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model', Journal of Molecular Neuroscience, vol. 45, no. 3, pp. 432-437. https://doi.org/10.1007/s12031-011-9604-5
Sydow, Astrid ; Van Der Jeugd, Ann ; Zheng, Fang ; Ahmed, Tariq ; Balschun, Detlef ; Petrova, Olga ; Drexler, Dagmar ; Zhou, Lepu ; Rune, Gabriele ; Mandelkow, Eckhard ; D'Hooge, Rudi ; Alzheimer, Christian ; Mandelkow, Eva Maria. / Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model. In: Journal of Molecular Neuroscience. 2011 ; Vol. 45, No. 3. pp. 432-437.
@article{6d7004c4904c407a822e8a6431b14994,
title = "Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model",
abstract = "The accumulation of proteins such as Tau is a hallmark of several neurodegenerative diseases, e.g., frontotemporal dementia (FTD). So far, many mouse models of tauopathies have been generated by the use of mutated or truncated human Tau isoforms in order to enhance the amyloidogenic character of Tau and to mimic pathological processes similar to those in FTD patients. Our inducible mice express the repeat domain of human Tau (Tau RD) carrying the FTDP-17 mutation ΔK280 in a {"}pro-aggregant{"} and an {"}anti-aggregant{"} version. Based on the enhanced tendency of Tau to aggregate, only the {"}pro-aggregant{"} Tau RD mice develop Tau pathology (hyperphosphorylation, coassembly of human and mouse Tau, synaptic loss, and neuronal degeneration). We have now carried out behavioral and electrophysiological analyses showing that only the pro-aggregant Tau RD mice have impaired learning/memory and a distinct loss of LTP. Remarkably, after suppressing the pro-aggregant human Tau RD, memory and LTP recover, while neuronal loss persists. Aggregates persist as well but change their composition from mixed human/mouse to mouse Tau only. The rescue of cognition and synaptic plasticity is explained by a partial recovery of spine synapses in the hippocampus. These results indicate a tight relationship between the amyloidogenic character of Tau and brain malfunction, and suggest that the cognitive impairment is caused by toxic human Tau RD species rather than by mouse Tau aggregates.",
keywords = "Aggregation, Frontotemporal dementia, Tau, Tauopathy, Transgenic mouse models",
author = "Astrid Sydow and {Van Der Jeugd}, Ann and Fang Zheng and Tariq Ahmed and Detlef Balschun and Olga Petrova and Dagmar Drexler and Lepu Zhou and Gabriele Rune and Eckhard Mandelkow and Rudi D'Hooge and Christian Alzheimer and Mandelkow, {Eva Maria}",
year = "2011",
month = "11",
doi = "10.1007/s12031-011-9604-5",
language = "English",
volume = "45",
pages = "432--437",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model

AU - Sydow, Astrid

AU - Van Der Jeugd, Ann

AU - Zheng, Fang

AU - Ahmed, Tariq

AU - Balschun, Detlef

AU - Petrova, Olga

AU - Drexler, Dagmar

AU - Zhou, Lepu

AU - Rune, Gabriele

AU - Mandelkow, Eckhard

AU - D'Hooge, Rudi

AU - Alzheimer, Christian

AU - Mandelkow, Eva Maria

PY - 2011/11

Y1 - 2011/11

N2 - The accumulation of proteins such as Tau is a hallmark of several neurodegenerative diseases, e.g., frontotemporal dementia (FTD). So far, many mouse models of tauopathies have been generated by the use of mutated or truncated human Tau isoforms in order to enhance the amyloidogenic character of Tau and to mimic pathological processes similar to those in FTD patients. Our inducible mice express the repeat domain of human Tau (Tau RD) carrying the FTDP-17 mutation ΔK280 in a "pro-aggregant" and an "anti-aggregant" version. Based on the enhanced tendency of Tau to aggregate, only the "pro-aggregant" Tau RD mice develop Tau pathology (hyperphosphorylation, coassembly of human and mouse Tau, synaptic loss, and neuronal degeneration). We have now carried out behavioral and electrophysiological analyses showing that only the pro-aggregant Tau RD mice have impaired learning/memory and a distinct loss of LTP. Remarkably, after suppressing the pro-aggregant human Tau RD, memory and LTP recover, while neuronal loss persists. Aggregates persist as well but change their composition from mixed human/mouse to mouse Tau only. The rescue of cognition and synaptic plasticity is explained by a partial recovery of spine synapses in the hippocampus. These results indicate a tight relationship between the amyloidogenic character of Tau and brain malfunction, and suggest that the cognitive impairment is caused by toxic human Tau RD species rather than by mouse Tau aggregates.

AB - The accumulation of proteins such as Tau is a hallmark of several neurodegenerative diseases, e.g., frontotemporal dementia (FTD). So far, many mouse models of tauopathies have been generated by the use of mutated or truncated human Tau isoforms in order to enhance the amyloidogenic character of Tau and to mimic pathological processes similar to those in FTD patients. Our inducible mice express the repeat domain of human Tau (Tau RD) carrying the FTDP-17 mutation ΔK280 in a "pro-aggregant" and an "anti-aggregant" version. Based on the enhanced tendency of Tau to aggregate, only the "pro-aggregant" Tau RD mice develop Tau pathology (hyperphosphorylation, coassembly of human and mouse Tau, synaptic loss, and neuronal degeneration). We have now carried out behavioral and electrophysiological analyses showing that only the pro-aggregant Tau RD mice have impaired learning/memory and a distinct loss of LTP. Remarkably, after suppressing the pro-aggregant human Tau RD, memory and LTP recover, while neuronal loss persists. Aggregates persist as well but change their composition from mixed human/mouse to mouse Tau only. The rescue of cognition and synaptic plasticity is explained by a partial recovery of spine synapses in the hippocampus. These results indicate a tight relationship between the amyloidogenic character of Tau and brain malfunction, and suggest that the cognitive impairment is caused by toxic human Tau RD species rather than by mouse Tau aggregates.

KW - Aggregation

KW - Frontotemporal dementia

KW - Tau

KW - Tauopathy

KW - Transgenic mouse models

UR - http://www.scopus.com/inward/record.url?scp=80855138109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855138109&partnerID=8YFLogxK

U2 - 10.1007/s12031-011-9604-5

DO - 10.1007/s12031-011-9604-5

M3 - Article

VL - 45

SP - 432

EP - 437

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 3

ER -